Aktis Oncology, Inc. (AKTS) revenue

Revenue · fiscal 2025
$6.50M

Aktis Oncology, Inc. (AKTS) reported revenue of $6.50M in fiscal 2025 (the year ended December 31, 2025). That is 336.9% higher than the $1.49M of fiscal 2024. Figures as of 18 Nov 2026, 11:41 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$6.50M
Change on fiscal 2024
+336.9%
Growth, 5 years
+29.4% a year
Highest on record
$6.62Mfiscal 2021
Lowest on record
$254.83Kfiscal 2016
Fiscal years on record
82016–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Aktis Oncology, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 29.4% a year. Across the 8 fiscal years on record (2016–2025), the highest was $6.62M in fiscal 2021 and the lowest $254.83K in fiscal 2016.

History · 8 fiscal years

Revenue by fiscal year

Aktis Oncology, Inc. revenue, year by year

Aktis Oncology, Inc. (AKTS) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$6.50M 336.9% up
2024$1.49M—
2021$6.62M 269.7% up
2020$1.79M 24.0% up
2019$1.44M 19.5% up
2018$1.21M 148.3% up
2017$486.50K 90.9% up
2016$254.83K—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on AKTS

Aktis Oncology, Inc., figure by figure

Aktis Oncology, Inc. (AKTS) overview: price, valuation and scorecard

Aktis Oncology, Inc. revenue: questions and answers

What is Aktis Oncology, Inc.'s revenue?

Aktis Oncology, Inc. (AKTS) reported revenue of $6.50M in fiscal 2025 (the year ended December 31, 2025). That is 336.9% higher than the $1.49M of fiscal 2024.

What is the growth rate of Aktis Oncology, Inc.'s revenue?

Over the five fiscal years to 2025 revenue grew at a compound 29.4% a year.

What are the highest and lowest revenue figures on record for Aktis Oncology, Inc.?

Across the 8 fiscal years on record (2016–2025), the highest was $6.62M in fiscal 2021 and the lowest $254.83K in fiscal 2016.

How is Aktis Oncology, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Aktis Oncology, Inc. it is on record here for 8 fiscal years, 2016 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Aktis Oncology, Inc. (AKTS) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/AKTS/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.